Heidi Schwarzenbach

11.4k total citations · 2 hit papers
105 papers, 9.0k citations indexed

About

Heidi Schwarzenbach is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Heidi Schwarzenbach has authored 105 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Cancer Research, 71 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Heidi Schwarzenbach's work include MicroRNA in disease regulation (41 papers), Cancer Genomics and Diagnostics (33 papers) and Circular RNAs in diseases (29 papers). Heidi Schwarzenbach is often cited by papers focused on MicroRNA in disease regulation (41 papers), Cancer Genomics and Diagnostics (33 papers) and Circular RNAs in diseases (29 papers). Heidi Schwarzenbach collaborates with scholars based in Germany, United States and Switzerland. Heidi Schwarzenbach's co-authors include Klaus Pantel, Dave S.�B. Hoon, George A. Călin, Volkmar Müller, Naohiro Nishida, Catherine Alix‐Panabières, Karin Milde‐Langosch, Carina Roth, Peter B. Gahan and Bettina Steinbach and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Heidi Schwarzenbach

104 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell-free nucleic acids as biomarkers in cancer patients

2011 2.2k citations Heidi Schwarzenbach, Klaus Pantel et al. profile →
Clinical relevance of circulating cell-free microRNAs in cancer

2014 862 citations Heidi Schwarzenbach, Klaus Pantel et al. profile →

Peers

Heidi Schwarzenbach

ONCOL

PRM

PFM

Burkhard Brandt Germany

Derek L. Stirewalt United States

Alain R. Thierry France

Fabio Petrocca United States

Hans‐Peter Sinn Germany

Scott V. Bratman Canada

David Hardisson Spain

Ellen Heitzer Austria

Jacqui Shaw United Kingdom

Stefano Indraccolo Italy

Burkhard Brandt Germany

Heidi Schwarzenbach

3.3k ×0.5

4.2k ×0.7

3.5k ×1.9

ONCOL

1.8k ×1.4

PRM

559 ×0.7

PFM

Citations per year, relative to Heidi Schwarzenbach Heidi Schwarzenbach (= 1×) peers Burkhard Brandt

Countries citing papers authored by Heidi Schwarzenbach

Since Specialization

Citations

This map shows the geographic impact of Heidi Schwarzenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Schwarzenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Schwarzenbach more than expected).

Fields of papers citing papers by Heidi Schwarzenbach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Schwarzenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Schwarzenbach. The network helps show where Heidi Schwarzenbach may publish in the future.

Co-authorship network of co-authors of Heidi Schwarzenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Schwarzenbach. A scholar is included among the top collaborators of Heidi Schwarzenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Schwarzenbach. Heidi Schwarzenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gahan, Peter B. & Heidi Schwarzenbach. (2023). A Comparative Review of the Detection of Early-stage Lung Cancer by Exosomal and Free Nucleic Acids and Standard Screening Methods. 0(0). 0–0. 2 indexed citations

Schwarzenbach, Heidi, et al.. (2022). MicroRNAs and their Implications in CD4+ T-cells,Oligodendrocytes and Dendritic Cells in Multiple SclerosisPathogenesis. Current Molecular Medicine. 23(7). 630–647. 6 indexed citations

Schwarzenbach, Heidi, et al.. (2022). A 3-year prospective randomized clinical trial of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials. SHILAP Revista de lepidopterología. 8(1). 5–5. 9 indexed citations

Hillebrand, Timo, et al.. (2018). Clinical relevance of size selection of circulating DNA. Translational Cancer Research. 7(2). 9 indexed citations

Schwarzenbach, Heidi. (2018). Methods for quantification and characterization of microRNAs in cell-free plasma/serum, normal exosomes and tumor-derived exosomes. Translational Cancer Research. 7(2). 3 indexed citations

Ni, Qingtao, Ines Stevic, Pan Chi, et al.. (2018). Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients. Scientific Reports. 8(1). 12974–12974. 62 indexed citations

Schwarzenbach, Heidi. (2016). Clinical significance of miR-15 and miR-16 in ovarian cancer. Translational Cancer Research. 5(1). 4 indexed citations

Budnik, Lygia Therese, Stefan Kloth, Xaver Baur, Alexandra M. Preisser, & Heidi Schwarzenbach. (2013). Circulating Mitochondrial DNA as Biomarker Linking Environmental Chemical Exposure to Early Preclinical Lesions Elevation of mtDNA in Human Serum after Exposure to Carcinogenic Halo-Alkane-Based Pesticides. PLoS ONE. 8(5). e64413–e64413. 35 indexed citations

Ell, Brian, Laura Mercatali, Toni Ibrahim, et al.. (2013). Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis. Cancer Cell. 24(4). 542–556. 228 indexed citations

10.

Schwarzenbach, Heidi. (2013). Circulating nucleic acids as biomarkers in breast cancer. Breast Cancer Research. 15(5). 211–211. 99 indexed citations

11.

Schwarzenbach, Heidi, et al.. (2012). Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression. Clinical Cancer Research. 18(20). 5719–5730. 50 indexed citations

12.

Kuhlmann, Jan Dominik, Heidi Schwarzenbach, Pauline Wimberger, et al.. (2012). LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival. BMC Cancer. 12(1). 325–325. 34 indexed citations

13.

Chang, Lydia, et al.. (2011). Expression Regulation of the Metastasis-Promoting Protein InsP3-Kinase-A in Tumor Cells. Molecular Cancer Research. 9(4). 497–506. 16 indexed citations

14.

Schwarzenbach, Heidi, Volkmar Müller, Karin Milde‐Langosch, Bettina Steinbach, & Klaus Pantel. (2011). Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease. Molecular BioSystems. 7(10). 2848–2854. 55 indexed citations

15.

Roth, Carina, Sabine Kasimir‐Bauer, Klaus Pantel, & Heidi Schwarzenbach. (2011). Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Molecular Oncology. 5(3). 281–291. 76 indexed citations

16.

Kuhlmann, Jan Dominik, Heidi Schwarzenbach, Friedrich Otterbach, et al.. (2011). Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapy. Genes Chromosomes and Cancer. 50(8). 598–605. 7 indexed citations

17.

Roth, Carina, Brigitte Rack, Volkmar Müller, et al.. (2010). Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Research. 12(6). R90–R90. 337 indexed citations

18.

Schwarzenbach, Heidi, Felix K.‐H. Chun, Sebastian Carpenter, et al.. (2007). Detection of tumor‐specific DNA in blood and bone marrow plasma from patients with prostate cancer. International Journal of Cancer. 120(7). 1465–1471. 45 indexed citations

19.

Schwarzenbach, Heidi. (2002). A diagnostic tool for monitoring multidrug resistance expression in human tumor tissues. Analytical Biochemistry. 308(1). 26–33. 5 indexed citations

20.

Schwarzenbach, Heidi, John W. Newell, & Patrick Matthias. (1995). Involvement of the Ets Family Factor PU.1 in the Activation of Immunoglobulin Promoters. Journal of Biological Chemistry. 270(2). 898–907. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact